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Cockayne syndrome (CS) is a rare autosomal recessive 
disease characterized by acute sun sensitivity , cachectic 
dwarfism, and neurologic a nd skeletal a bnormalities. 
Cultured skin fibroblasts from patients with this disease 
are known to be hypersensitive to the lethal effects of 
254-nm UV radiation. We have studied the sensitivity 
to 254-nm UV radiation of lymphoblastoid lines derived 
from 3 typical CS patients, 1 atypical CS patient who 
had a very late age of onset of clinical manifestations, 2 
patients who had both xeroderma pigmentosum (XP) 
and typical CS , and 3 heterozygous parents of these 
patients. Post-UV survival was determined by the try-
pan-blue dye-exclusion method. 
The lymphoblastoid lines from the 3 typical CS pa-
tients, the atypical CS patient, and the 2 patients with 
both CS and XP had decreased post-UV viability in 
comparison with lines from normal donors. Lines from 
the heterozygous parents had normal post-UV viability. 
The post-UV viability of the typical CS lines was similar 
to that of a XP complementation group C line. The 
relative post-UV viability of lymphoblastoid lines from 
the typical CS patients was similar to the relative post-
UV survival of their fibroblast lines. The lymphoblas-
toid line from the atypical CS patient had a post-UV 
viability similar to that of the typical CS patients. Thus, 
the relative hypersensitivity of CS patients' cells in vitro 
does not reflect the severity or age of onset of the pa-
tients' clinical manifestations. The lymphoblastoid lines 
from the 2 patients who had both CS and XP were 
significantly more sensitive to the UV radiation than 
those from patients with only CS. 
Our studies demonstrate that lymphoblastoid lines 
from patients with CS are appropriate and useful cell 
lines for the study of the inherited hypersensitivity to 
UV radiation . 
Cockayne syndrome (CS) is a ra re autosomal recessive dis-
ease cha racte rized by acute sun sensit ivity, cachectic dwarfism, 
skeletal abnormalities, pigmenta ry retinal degeneration, and 
progressive neurologic defects including dementia [1- 6]. Cul-
tured skin fibrob lasts from CS patients are hypersensitive to 
t he lethal effects of 254-nm UV radiation [7 ,8] but have no 
detectable defects in nucleotide exc is ion repair [6- 9] or post-
replication repair [9,10] . Fibroblasts from patients with xero-
derma pigmentosum (XP) , another rare autoso mal reces-
sive di sease, also show a hypersensitivity to UV radiation [6, 11-
1:3]. However, most XP fibrob lasts are deficient in nucleotide 
excision repair [6,12,13] and in postreplication repair [6, 
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13-15]. 
Epstein-Barr virus-transformed lymphoblastoid lines derived 
from peripheral blood B lymphocytes have proved very useful 
in studying the inherited hypersensitivity of XP cells to 254-
nm UV radiat ion [16]. We therefore studied lymphoblastoid 
lines derived from several CS patients to determine (1) whether 
t he lines manifest t he CS phenotype of cellular hypersensitivity 
to UV radiation in terms of ce ll survival, (2) whether such 
cellular hypersensitivity can be reliably quantified, and (3) 
whether the degree of hypersensit ivity to UV radiation ref1 ects 
t he severity or age of onset of the patients' clinical abnormali -
t ies . 
We studied lymphoblasto id lines from 3 typical CS patients, 
1 atyp ical CS patient who had a late age of onset and mild 
clinical features, 2 patients known to have both XP and CS 
and 3 heterozygous parents of t hese patients. ' 
MATERIALS AND METHODS 
Lymphoblastoid Lines 
All the lymphoblasto id lines were deri ved by transforming peripheral 
blood lymphocytes with Epstein -Barr virus. All lines a re available from 
The Human Genet ic Mu tant Cell Repository, Copewood and Davis 
Streets, Ca mden, New ,Jersey. The patients' lymphoblastoid lines used 
for post- UV surviva l experiments a re prese med in Table 1. T able It 
compares the relevant clinica l features of 2 of the typical CS patients 
with the features of the atypica l CS pat ient. The lym phoblasto id lines 
from normal co ntrols used for post-UY surviva l experiments were GM 
333, 536, 558, 606, 621, 892, 923, a nd RB 4580. Additional lines used 
for post.-x -ray survival experiments were as follows: 22 normal: GM 
1 ~0.333 , 536,558,606,621,892,923, 1056, 1310,1956,2148,3928, RB 
4083,4467 , 4469, 4579, 4580,4604, 5830, E-1, R-1; ataxia te langiectasia: 
GM 717, 1526; ata xia tela ngiectas ia heterozygote: GM 3187,3188. 
Culture and l rradiation Technique 
T he lymphoblastoid lines were cultured and irradiated as described 
previously [16,25]. The lines were ma intained in stock cultures a1 
concent rations between 2 x 105 and 3 X 106 cells/ml at 37•c in a 
humidified atmosphere of 5% C0 2:95% air in RPM! medium 1640 
(Gibco) conta ining 20% fetal bovine serum (Gibco) . T he mean growth 
ra te of t.he unirradiated normal lines was not s ignificantly different 
from that of the pa t ient lines. Half a n hour before irrad iation, 0.5 ml 
of the ce ll suspension was mixed witb 1.5 ml of trypan-blue solut ion 
(0.4% in normal saline, Gibco) and the viable (i.e., t.rypan-blue-exclud-
ing) ce lls were counted in a hemocytometer. 
For post-UV surviva l experiments the cu lture medium was cent ri-
fu ged at 600 1J for 10 min , and the ce lls were resuspended to a concen-
tration of approx imately 3.2 x 106/ ml of Hanks' bala nced salt solu t ion 
(without phenol red). The ce lls were then irradiated with 254-nm V 
radiation at a flu x of 0.08 Jfm" from a ge rmicida l lamp (General 
E lectric, No. Gl 5T 8). Immediately after the t ime of irradiation, each 
volume of the ce ll suspension was diluted with 7 volumes of fresh 
medium , and the cells were incubated for 3 days, when t he viable ce lls 
were determined by tbe trypan-blue-exclusion method. T o determine 
the post -U Y viab ili ty in some time-course experiments, irradia ted a nd 
unirradiated ce lls were incubated for an additional 5, 7, or 10 days. 
Post -x-ray survival ex periments we re performed as described previ-
ously [26] except t hat stoc k cultures were diluted with fresh medium 
to give a cell concentration of approximate ly 3 X 105/ ml. 
Su rvival Parameters and Statistical Analysis 
The post irradiation viability ratio of the lymphoblastoid lines was 
calculated by dividing the concentra tion of viable ce lls in an irradiated 
culture on the third postirradiation day by the concentration of viable 
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TABLE I. Clinical and laboratory characterization of lym.phobla.<~toid line donors 
Designation Complement.a -
t.ion group 
Ce ll line Diagnosis Age Sex Acute sun Comment Refe rence 
Cell sensitivity 
Lympho- cs XP donoru 
blast.oid Fibroblast. 
CS2BE GM I71 2 GM 1098 cs 21 M B + T ypical CS 8,9,17 
CS3BE GM 1857 GM 1856 cs 13 M A + Typical CS 8.9,17 
CS1FABE RB 5325 RB 5324 cs 5 M ?" Typical CS 18' 
Atypical CS GM 2964 GM 2965 cs 25 F A + Atypical CS 10,19 
CSHM1BE GM 2474 CS het" 29 M Clinica lly normal 
father of CS1BE 
CSHM1FABE RB 5323 RB 5322 CS het 30 M Clinica lly normal 
father ofCSlFABE 
XP-CS-1 GM 2252 XP -CS 31 F c B + Affected with both 12,17,20 
(XPllBE) XP a nd typical CS 
(CS4BE) 
XP-CS het F XP-CS-HF-1 GM 1855 GM 1854 64 Clinica lly no rmal 
moLher of XP-CS-1 
XP-CS-2 G M 3249 GM 3248 XP-CS 5 M H + Affected with both 21,22 
(XP-SC-8) XP and typ ica l CS 
XP12BE GM 2250 XP 10 F A + 12,20,23 
XPHF12BE GM 5511 GM 5510 XP het 44 F Clinical ly normal 
mother of XP12BE 
XPHM 12BE GM 5569 GM 5568 XP het 47 M Clinica lly normal 
fathe r of XP12BE 
XP20S GM 2345 GM 4419 XP 8 F A + 24 
XP3BE GM 2248 GM 0030 XP 25 M c + 12,20,23 
XP9BE GM 2498 GM 0676 XP 16 M c 12,20 
XP17BE GM 2253 XP 14 M D + 11 
~e desig-nation of CS2BE signifies t he second CS patient who was studied clinica lly at, or whose cell line was studied at, t he NIH , Bethesda, 
Maryland. BE, Bethesda, Maryland; FA, Fargo, North Dakota; OS, Osaka, Japan. Heterozygotes are indicated by the lette r H, with male and 
female being designated by M and F, respect1vely. Alternative, prevwusly published designations a re shown in parentheses. 
b No re liab le history conce rning the presence or absence of acute su n sensitiv ity could be obtained (personal communication, R. A. Brumback). 
c The patient. whose autopsy is described in this reference is the s ister of patient CS1FABE. 
d het = heterozygote. 
TABLE II. Clinical feal.ures of two typical CS patients and of the atypical CS patient 
Typical CS patients• 
Age' (sex) 
Age (yr) of clinical onset 
Cachectic dwarfism 
Height (em) 
Weight (kg) 
Acute sun se ns it ivity 
Ret ina l pigmentation 
Optic atrophy 
Sensorineura l deafness 
Me n ta l status 
Normal pressure hydropcepha lus 
C h o reoathetosis 
Ataxia 
Gait disturbance 
Hyperreflexia and clonus 
Incontinence (urinary and fecal) 
Sexual development 
21 (M) 
1 
Severe 
84 
7.3 
+ 
+ 
+ 
Severe 
CS2BE 
At 3 yr 9 mod: Binet IQ 66 (2 yr 5 
mo) '' ; at 4 yr 10 mo: Binet !Q 62 
(3 y r) ; at 21 yr: lQ un testab le 
+ 
+ 
+ 
+ 
+ 
+ 
In fan t ile 
a Data from Brumback eta! [17]; + = present. 
• Data from Kennedy et al [19 ); + = present;-= absent. 
12 (M) 
1 
Severe 
105 
14.4 
+ 
+ 
+ 
Severe 
CS3BE 
At 5 y r 5 mo: B inet lQ 52 (3 yr 1 
mo); at 12 yr 8 mo: S losson IQ 
31 (4 yr 1 mol 
+ 
+ 
+ 
+ 
+ 
+ 
infantile 
<Age at last clinical observation a nd/or age of sk in biopsy and venipuncture (for establishing ce ll lines ). 
d Age at !Q test ing. 
• Mental age. 
I The IQ test administered is not known. 
Atyp ical CS patient.• 
25 (F) 
5 
Mild 
145 
32 
+ 
Mild 
Graduated from high 
school and au.e nded jun-
ior college; IQ was 78 
when tested in high 
school' 
Late onset 
Minimal 
Successful pregnancy 
cells in an unirradiated culture of the same line on t he same day [1 6]. 
At least 4 replicate expe rimen ts were performed on each line. 
For analysis of t he dose- response curves, stra ight lines were fit by 
t he method of least squa res t hrough the 4, 6, and 10 J/m 2 doses for the 
normal lines, t hrough the 2 J/m 2 and a ll higher doses for t he CS lines, 
and through the 1 J/m2 and a ll higher doses for t he XP and XP-CS 
lines. The D0 value is the negative inverse of t he slope of th is straight 
line and corresponds to t he dose of UV radiation which reduces survival 
from a ny point on t he stra ight line to 37% of t hat point. The extrapo-
lation number is the value on t he Y axis at which the extrapo lation of 
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the st raight line port ion of a su rvival curve intercepts t he Y axis. 
T here was no correlation between the post irradiation viab il ity ratio 
and either t he donor age or t he growt h rate of unirradiated lines. T he 
stat is t ica l a nalyses were performed using analysis of varia nce methods 
[27], and 2-sided p values are reported . 
RESULTS 
T he survival of t he lymphoblastoid lines after irradiation 
with 6 J/m2 of UV radiation is graphed in Fig 1. The mean 
post-UV viability ratios of the 4 CS, the 5 XP, and t he 2 XP -
CS lines we re each significantly less (p < w-") than that of 
the normal cont rols (Fig 1). The 2 XP-CS lines had a mean 
post-uv viabili ty ratio which was significant ly less than that 
of t he 4 CS lines ( p = 0.012). T he differences in post-UV 
viabili ty among the 4 CS lines, including the line from t he 
atypica l patien t , were not significant. T he XP group C line GM 
2498 (0 ) from patient XP9BE had a significant ly higher post-
UV viabili ty ratio t han each of t he other XP lines (p < 0.01) . 
T he XP-CS-1 line GM 2252 (~) was more sensit ive to UV 
radiation t han t he XP-CS-2 line GM 3249 (~) ( p = 0.01) . The 
CS, XP-CS, and XP lines were not hypersensit ive to x- rays. 
T he post-UV viability of the heterozygote lines (2 CS, 1 XP-
CS, 2 XP) was within t he normal range (Fig 1) . 
Fig 2 and Table III show the resul ts of UV dose- response 
experiments. T he 3 normal control lines had t he highest sur-
vival at a ll doses tested (Fig 2). Each of their curves has a 
posit ive shoulder, i.e., an init ial port ion which extends to t he 4 
J/m2 dose and which has little downward slope. The mean Do 
value for t he normal lines was 7.5 (Table Ill) . T here were no 
signi ficant diffe rences among t he Do or extrapolation values of 
t he normal lines. 
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FIG l . Surv iva l of lymphoblasto id lines on the t hird day a fte r ex -
posure to 254-nm UV radiation (6 J / m2). Eac h symlJo l represents the 
mean post -UV viabili ty ratio of t he replicate experiments performed 
on a cell li ne. Normal cont rol li nes, e. CS: GM 1857, +; GM 1712, 'f'; 
RB 5325 , •; GM 2964, .&. XP: GM 2498, 0; GM 2250, 'V; GM 2253, 0 ; 
GM 2345, b.; GM 2248, 0 . XP-CS: GM 3249, 0; GM 2252, l;l. Hetero-
zygotes: RB 5323, 'V ; GM 2474 , b. ; GM 5569, CD; GM 5511 , 8 ; GM 1855, 
El. 
Vol. 82, No. 5 
1.00 
\ 
I \ 
~I 'q 
'\\ \ ~\I I'> \ ~ 
0 '\ \~\ 
1--
I' \ <{ \ ~'\. \ a: 
>-
I \ ' \ 
!::= 0.10 \ ~'~ \ '\ \ \ \ ' ' 
__J 
' \ "' co <{ ' \~ CS3BE 
> \ \ ,, 
\ '" > \ \ \ ' 
::> \ 6\ \ "e XP-CS-2 
~ I \ \ \ \ \ 
(j) I ' 'tJXP17BE 0 \ \ \ XP9BE a... \ I \ 
,6 XP20S \ \ CS2BE 
0.01 ' 
\ x P-CS-1 
0 2 4 6 8 10 
UV DOSE (J/m2) 
F IG 2. Dose- response cu rves of t he post- UV su rv ival of lympho-
blastoid lines on the third day a fte r irrad iation wit h 254 -nm UV 
rad ia t ion . Normal lines: GM 333, GM 536, GM 62 1. Symbols as in 
lege nd of F ig 1. 
The dose- response cmves fo r the 4 CS, 3 XP, and 2 XP-CS 
lines lacked t he positive shoulder of t he normal cont rol lines 
and were below the normal curves at a ll doses tested. The 4 CS 
curves were grouped together nea r the curve fo r XP group C 
line GM 2498 from patient XP9BE. The mean Do value of 2.6 
fo r the 4 CS lines (Table III ) was significant ly less t han t hat 
of the normal lines (p < w-•). The Do value of 2.3 fo r GM 
1712 (CS2BE) was less t han the value of 3.3 for GM 1857 
(CS3BE ) ( p = 0.06) . A simila r difference in relative survival 
was obta ined after UV irradiation of t he fibroblast lines from 
t hese 2 CS patients [8]. T here were no significant di fferences 
among the extrapolation numbers of t he 4 CS lines. Their mean 
extrapolation number of 1.2 was significantly less than that of 
t he normal lines (p = 0.008). The dose- response curve of t he 
atypical CS patient GM 2964 was between that of GM 1712 
(CS2BE) and GM 1857 (CS3BE). The Do and extrapolation 
number for GM 2964 were not significant ly different from the 
corresponding values for the other CS patients. 
Dose-response curves were obtained fo r 3 of t he XP lines. 
T he group C line GM 2498 (from patient XP9BE) had a Do 
value of 2.5 (Table III) which was signi ficant ly higher t han 
that of the other 2 XP lines (p < 0.018). The Do value of 1.6 
for the XP group A line GM 2345 from patient XP20S was not 
significantly diffe rent from that of 1.5 for the group D line GM 
2253 from patient XP17BE (p > 0.50). However, t he dose-
response curve for GM 2345 differed from that of GM 2253 in 
that it comprised 2 components: the first component is very 
steep and extends to the 1 J / m2 dose; t he second component , 
which is less steep, is exponent ia l and extends from 2 J / m2 
t hrough 6 J / m2 • The steep init ial component of such a 2-
component survival curve has been described as a "negative 
shoulder" [11], and the second component is characterized not 
only by its Do value but also by its ext rapolation number of 0.5 
which is significantly less t han 1.0 ( p = 0.019). 
The curve for line GM 3249 from patient XP-CS-2 is a lso a 
2-component curve, and its ext rapolation number of 0.4 is 
sign ificant ly less than 1.0 (p = 0.005). The dose-response curve 
for line GM 2252 from patient XP -CS-1 had a D0 value of 0.8 
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TABLE II f. Post- UV su rvival parameters of lymphobla.~toid lines in. 
dose-response experiments 
Line' Do• 
Extrapola tion 
numberb 
Normals 
G M 558 8.2 1.4 
G M 333 7.2 1.5 
G M 621 7.1 1.4 
7.5 l.5 
(± 0.4) (± 0.03) 
cs 
GM L857 3.3 l.3 
GM 2964 2.6 l.l 
RB 5325 2.4 1.2 
GM 1712 2.:3 1.2 
2.6 1.2 
(± 0.2) (± 0.04) 
P < w-·• p = 0.008 
XP-CS 
GM 3249 2.4 0.4 
GM 2252 0.8 0.9 
1.6 0.6 
(± 0.8) (± 0.3) 
p = 0.004 p = 0.026 
XP 
GM 2498 2.5 1.1 
GM 2253 l.5 1.2 
G M 2345 L.6 0.5 
1.9 0.9 
(± 0.3) (± 0.2) 
p = 0.0003 p = 0.087 
a T he Do is t he dose reducing survival from a ny point on t he expo-
nentia l portion of t he survival curve to ~H% of that. point. Fi gures in 
pare nt heses represent SEM; p value for comparison wit h normal. 
b T he extrapolation number 1s the va lue of t he Y ax1s at wh1ch t he 
extens ion of the exponential portion of the survival curve intersects 
t he y ax is. Figures in parentheses repre ·ent SEM; p value fo r compar-
ison wit h normal. 
which was significantly lower tha n t hat of any other line (p < 
0.05). The mean Do value of 1.6 for these 2 ?CP-CS lines was 
s ignificantly less than that of the 3 normal lines (p = 0.004). 
The D for GM 3249 was in the range of the Do values of the 
CS lin~s; however, t he Do for GM 2252 was significantly lower 
t han the Do value of t he 4 CS lines (p = 0.001) . The mean 
extrapolation number of 0.6 for the 2 XP-CS lines was signifi -
cantly less t han that of the 3 normal lines ( p = 0.026) and t hat 
of the 4 CS lines (p = 0.05) . 
Additional experiments were conducted with t he atypical CS 
patient line GM 2964 and wit h the lines from 2 of the typical 
CS patients (GM 1857 and GM 1712). After these lines were 
irradiated with 10 J/m~, t here were no viable GM 1712 cells by 
the tenth postirradiation day, at which time a ll t he other lines 
had surviving ce lls which were proliferating. When lines GM 
1857 and GM 2964 were irradiated with 12 J / m2 , on ly the GM 
1857 line had viable cells left by t he tenth postirradiation day. 
Th us these addi t iona l studies confirmed t hat the line from the atypi~a l CS patient had a reactivity to UV radiation between 
t hat of the 2 typical CS patients. 
DISCUSSION 
CS is a n autoso mal recessive di sease characterized by cach-
ectic dwarfism, skeletal abnormalit ies, sexual infant ilism, neu-
rologic ab normalities, and acute sun sensit ivity [1-6]. While 
there can be great differences in t~e occurrence of these clinical 
features among CS patients (see , for example, T able II com-
paring the atypica l CS patient with t he typical CS patients) , 
no patients ident ified as having typical CS are known not to 
have had ac ute sun sensitivity. In cont rast, many XP patients 
have never had acute sun sensitivi ty [12], and their cultured 
cells are less sensitive to the lethal effects of UV radiation than 
are cells from XP patients wi th acute sun sensitivity (Figs 1, 
2) [11] . Since the degree of hypersensitivity of cultured cells 
from CS patients with acute sun sensitivity is simi lar to that 
of patient XP9BE (Figs 1, 2) who had no acute sun sensit ivi ty 
(Table I) , the hypersensitivi ty to UV radiation of CS cells in 
vi t ro and in vivo is likely to be caused by a different type of 
DNA repair defect t han that of XP patients. As described 
below, important differences have been found between t he CS 
and XP DNA repair defects. 
There a re several other clinical differences between CS and 
XP. CS patients, wit h t he exception of those with both XP and 
CS, do not deve lop chronic actinic skin damage such as exces-
sive frec kles or sunlight- induced skin cancers. The extreme 
cachectic dwarfism of CS is not seen in XP patients, and XP 
patients lack the skeletal abnormali t ies seen in CS. The neu-
rologic abnormali ties of CS are principally due to demyelina-
tion, while t hose of XP a re due to a primary neuronal degen-
eration [1 2]. T hus, t he clinical manifestations of CS differ in 
most important respects from t he clinical manifestations of 
XP. Cul tured CS cells, like XP cells, are (l) hypersensitive to 
the letha l effects of UV radiation [6-9,28] and UV-mimetic 
chemicals [6,9,28], (2) abnormally sensitive to the UV radia-
tion -induced inhibi tion of DNA and RNA synthesis [29], and 
(3) abnormal in the host-ce ll reactivation of UV -irradiated 
viruses [30- 32]. However, in contrast to cultured XP cells, CS 
cells have normal rates of postrep lication repair [9,10] and UV-
induced unscheduled DNA synt hesis [6- 9]. Like XP cells, CS 
cells have a normal sensit ivity to ion izing radiation, indicating 
that the hypersensit ivity of CS lymphoblastoid lines to UV 
rad iation is not a genera l response to a ll types of DNA-dam-
aging age nts. 
In our study of t he post -UV surviva l of 9 CS fibroblast lines 
[8], we observed the following features of the CS sensitivity to 
UV radiation: (l) each CS fibroblas t line had significantly lower 
post- UV colony-forming abili ty t han each normal line; (2) whi le 
the post-UV colony-forming ab ility of the least sensitive CS 
fib roblast line differed significant ly from that of the most 
sens it ive line, t he di fferences in post- UV colony-forming abil ity 
among the CS fib roblast lines were less than those between XP 
fibroblast lines [11]; and (3) t he hypersensitivity of CS fibro -
blast lines to UV radiation was not as great as that of t he most 
sensitive XP lines [11] . We have now demonstrated similar 
features with CS lymphoblastoid lines: (l) each CS lymp ho-
blastoid line was significant ly more sensitive to UV radiation 
than each normal line; (2) while t here can be significant differ-
ences in post-UV viability among t he CS lymphoblastoid lines, 
t hese differences were less t han those among XP lymp hoblas-
toid lines [16]; furt hermore, the CS patient (CS2BE) whose 
fibroblast line was significant ly more sensitive than the libra-
blast line from patient CS3BE [8] had a lymphoblastoid line 
that was more sensitive than the lymphoblastoid line from 
patient CS3BE (Fig 2); (3) t he hype rsens it ivity of CS lympho-
blastoid lines to UV radiation was not as great as t hat of t he 
most sensit ive XP lymp hoblastoid lines (Fig 2) . T hus, our study 
of CS lymp hoblastoid lines reveals them to manifest the same 
qualitative and quantitative featu res ofpost-UV survival as CS 
fibroblast lines. 
Our resul ts show that t he 1 XP-CS, t he 2 CS, and the 2 XP 
obligate heterozygote lines were not hypersensit ive to UV ra-
diation. Therefore, t he lymphoblastoid-line trypan-blue-exclu-
sion assay cannot be used to ident ify such heterozygotes. Re-
garding such heterozygote detection , post-UV colony-forming 
abili ty studies with CS fibroblast lines have yielded conflicting 
resul ts. Marsha ll et al [33) found no hypersensitivity in 2 CS 
hete rozygote lines, while Wade and Chu [9] found a slight 
hype rsensit ivi ty in 4 heterozygote lines; however, in t he latter 
study, only 2 normal lines were used. Since it is known that 
there can be significa nt differences in post-UV colony-forming 
abili ty among normal fibroblast lines [11,34), t he claim by 
Wade and Chu [9] t hat CS heterozygote fibroblast lines a re 
hypersensit ive to UV radiation should be viewed wit h caution 
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until con fi rmed in a study us ing a la rge r number o f normal 
lines. 
In 1980, Kennedy et al [19] repo rted a patien t with an 
atypical c linical p icture of CS. While this patient, whose lym-
phoblastoid line is designated GM 2964, had acute sun sensi-
t ivity, she had o nly mild manifestations of CS (Table II). She 
graduated from high school, attended junior college, and had a 
su ccessful pregna ncy. Complementation studies [35] using fi-
broblasts from this atypical CS patient have shown her to be 
in CS complementation group A which also includes patient 
CS3BE; fusing he r fibroblasts with those of CS3BE did not 
restore to norma l the post-UV inhibition of RNA synthesis in 
the fused cells. Since this a t ypical patient's lymphoblastoid line 
GM 2964 is as sens it ive to UV radiation as the lines from t he 
typical CS patie n ts (Figs 1, 2), we conclude t hat, with the 
exception of acute sun sensitivity, the severity a nd age of onset 
of t he clinical manifestations we have evaluated in CS did not 
correlate with the degree of hypersens itivity of the pat ient's 
cult ured cell s. It should be noted , however, that the CS hyper-
sen s it ivi ty to t he UV type of DNA dam aging agent may still be 
t h e etiology, directly o r indirectly, of a ll the clinical manifes-
tations of CS. The hypersensitivity to UV radiation of CS cells 
appears to be the result of a faulty DNA repair mechanism, for 
C S cells a re unable to repa ir normally UV -irradiated viruses 
[30- 32). In order for defects in DNA repair to be clinica lly 
appare n t , t he DNA must be damaged. In t he skin of CS and 
XP patients, t his damage is caused by the UV radiation in 
sunligh t . In t he ne rvous system of XP patients and, presum-
ably, a lso in t he othe r non-sun -exposed a ffected tissues of CS 
patients, t he DNA damage could be caused by endogenous 
metabolites a nd by spontaneous hydrolytic reactions (such as 
t hose described by Linda hl [36]) . If the amount of damage 
varied a mong CS p atie n ts, different degrees of clinica l mani-
festations would result even in t he presence of the same quan-
titative defects in DNA repair. 
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